Yves Horsmans - Publications, H-index & Citations

Yves Horsmans

cliniques universitaires saint-luc and institut de recherche clinique

58H指数

363论文数

1.3W被引数

收录论文 132

发表时间

Correction: Liver Safety of the Dual Neurokinin‑1/‑3 Receptor Antagonist Elinzanetant 更正：双神经激肽-1/-3受体拮抗剂Elinzanetant的肝脏安全性

Drug Safety

IF3.8

2026-04-17

OAAI

James H. Lewis; Raúl J. Andrade; Dominique Larrey; Yves Horsmans; Richard A. Anderson; Mila Trajanovic; Esther Groettrup-Wolfers; Lineke Zuurman

Low level of awareness and prevention of hepatitis B among Congolese healthcare workers: urgent need for policy implementation

FRONTIERS IN PUBLIC HEALTH

IF3.4

2024-10-08

OAAI

Shindano, Tony Akilimali; Horsmans, Yves

Drug-induced liver injury related to gene therapy: A new challenge to be managed 与基因治疗相关的药物性肝损伤: 需要应对的新挑战

LIVER INTERNATIONAL

IF5.2

2024-09-09

PREAI

Larrey, Dominique; Delire, Benedicte; Meunier, Lucy; Zahhaf, Amel; de Martin, Eleonora; Horsmans, Yves

Evaluation of a Ten-Antigen Immunodot Test in Autoimmune Hepatitis and Primary Biliary Cholangitis: Lessons Learned for a Tertiary Care Academic Hospital

DIAGNOSTICS

IF3.3

2024-08-28

OAAI

Zorzi, Giulia; Pokem, Perrin Ngougni; Dahlqvist, Geraldine; Delire, Benedicte; Lanthier, Nicolas; Starkel, Peter; Horsmans, Yves; Aupaix, Cedric; Jnaoui, Samia; Gruson, Damien

AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults

RADIOLOGY

IF15.2

2023-06-01

OAAI

Nachit, Maxime; Horsmans, Yves; Summers, Ronald M.; Leclercq, Isabelle A.; Pickhardt, Perry J.

Toll-like receptor 2 activation in monocytes contributes to systemic inflammation and alcohol-associated liver disease in humans

HEPATOLOGY COMMUNICATIONS

IF4.6

2023-05-01

OAAI

Maccioni, Luca; Kasavuli, Joyce; Leclercq, Sophie; Pirlot, Boris; Laloux, Geraldine; Horsmans, Yves; Leclercq, Isabelle; Schnabl, Bernd; Starkel, Peter

Serum keratin 18-M65 levels detect progressive forms of alcohol-associated liver disease in early noncirrhotic stages

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH

IF2.7

2023-04-27

OAAI

Maccioni, Luca; Horsmans, Yves; Leclercq, Isabelle; Schnabl, Bernd; Starkel, Peter

Perinatal, metabolic, and reproductive features in PPARG-related lipodystrophy

EUROPEAN JOURNAL OF ENDOCRINOLOGY

IF5.2

2023-02-21

PREAI

Gosseaume, Camille; Fournier, Thierry; Jeru, Isabelle; Vignaud, Marie-Leone; Missotte, Isabelle; Archambeaud, Francoise; Debussche, Xavier; Droumaguet, Celine; Feve, Bruno; Grillot, Sophie; Guerci, Bruno; Hieronimus, Sylvie; Horsmans, Yves; Nobecourt, Estelle; Pienkowski, Catherine; Poitou, Christine; Thissen, Jean-Paul; Lascols, Olivier; Degrelle, Severine; Tsatsaris, Vassilis; Vigouroux, Corinne; Vatier, Camille

Duodenal CD8+T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol-associated liver disease in humans

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2022-08-02

OAAI

Maccioni, Luca; Loriot, Axelle; Dewulf, Joseph; Bommer, Guido; Horsmans, Yves; Lanthier, Nicolas; Leclercq, Isabelle; Schnabl, Bernd; Staerkel, Peter

Diagnosis of hepatitis C-related liver disease in patients with mild hemophilia

EUROPEAN JOURNAL OF INTERNAL MEDICINE

IF6.1

2021-09-01

PREAI

Krumb, Evelien; Lambert, Catherine; Horsmans, Yves; Hermans, Cedric

Rationale of adding muscle volume to muscle fat infiltration in the definition of an adverse muscle composition is unclear

JHEP REPORTS

IF7.5

2021-04-01

OAAI

Nachit, Maxime; Horsmans, Yves; Leclercq, Isabelle

Myosteatosis rather than sarcopenia associates with non-alcoholic steatohepatitis in non-alcoholic fatty liver disease preclinical models

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE

IF9.1

2020-11-26

OAAI

Nachit, Maxime; De Rudder, Maxime; Thissen, Jean-Paul; Schakman, Olivier; Bouzin, Caroline; Horsmans, Yves; Vande Velde, Greetje; Leclercq, Isabelle Anne

Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans

GUT MICROBES

IF11

2020-06-26

102

OAAI

Maccioni, Luca; Gao, Bei; Leclercq, Sophie; Pirlot, Boris; Horsmans, Yves; De Timary, Philippe; Leclercq, Isabelle; Fouts, Derrick; Schnabl, Bernd; Starkel, Peter

Drug-Induced Liver Injury and COVID-19 Infection: The Rules Remain the Same

DRUG SAFETY

IF3.8

2020-06-08

OAAI

Olry, Alexandre; Meunier, Lucy; Delire, Benedicte; Larrey, Dominique; Horsmans, Yves; Le Louet, Herve

Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital

BMC INFECTIOUS DISEASES

IF3

2019-08-22

OAAI

Goletti, Sylvie; Zuyten, Simeon; Goeminne, Leonie; Verhofstede, Chris; Rodriguez-Villalobos, Hector; Bodeus, Monique; Starkel, Peter; Horsmans, Yves; Kabamba-Mukadi, Benoit

Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injury

JOURNAL OF HEPATOLOGY

IF33

2019-06-01

OAAI

Manco, Rita; Clerbaux, Laure-Alix; Verhulst, Stefaan; Nader, Myriam Bou; Sempoux, Christine; Ambroise, Jerome; Bearzatto, Bertrand; Gala, Jean Luc; Horsmans, Yves; van Grunsven, Leo; Desdouets, Chantal; Leclercq, Isabelle

Real-world effectiveness and safety of glecaprevir plus pibrentasvir in HCV: A multi-country analysis of postmarketing observational studies

JOURNAL OF HEPATOLOGY

IF33

2019-04-01

PREAI

Lampertico, Pietro; Peck, Markus; Bondin, Mark; Horsmans, Yves; Semmo, Nasser; Sonparote, Sadhana; Zhang, Zhenzhen; Porcalla, Ariel; Thabut, Dominique

Activation of brown adipose tissue enhances the efficacy of caloric restriction for treatment of nonalcoholic steatohepatitis

LABORATORY INVESTIGATION

IF4.2

2019-01-01

OAAI

Poekes, Laurence; Gillard, Justine; Farrell, Geoffrey C.; Horsmans, Yves; Leclercq, Isabelle A.

Does haemophilia slow down the development of liver fibrosis?

HAEMOPHILIA

IF3

2018-11-14

OAAI

van Dievoet, Marie-Astrid; Leclercq, Isabelle; Hermans, Cedric; Lambert, Catherine; Horsmans, Yves; Jacquemin, Marc; Eeckhoudt, Stephane

Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

IF12

2018-03-01

181

OAAI

Asselah, Tarik; Kowdley, Kris V.; Zadeikis, Neddie; Wang, Stanley; Hassanein, Tarek; Horsmans, Yves; Colombo, Massimo; Calinas, Filipe; Aguilar, Humberto; de Ledinghen, Victor; Mantry, Parvez S.; Hezode, Christophe; Marinho, Rui Tato; Agarwal, Kosh; Nevens, Frederik; Elkhashab, Magdy; Kort, Jens; Liu, Ran; Ng, Teresa I.; Krishnan, Preethi; Lin, Chih-Wei; Mensa, Federico J.

研究方向